Identification of a Single Amino Acid in GluN1 That is Critical for Glycine-primed Internalization of NMDA Receptors
Overview
Neurology
Affiliations
Background: NMDA receptors are ligand-gated ion channels with essential roles in glutamatergic synaptic transmission and plasticity in the CNS. As co-receptors for glutamate and glycine, gating of the NMDA receptor/channel pore requires agonist binding to the glycine sites, as well as to the glutamate sites, on the ligand-binding domains of the receptor. In addition to channel gating, glycine has been found to prime NMDA receptors for internalization upon subsequent stimulation of glutamate and glycine sites.
Results: Here we address the key issue of identifying molecular determinants in the glycine-binding subunit, GluN1, that are essential for priming of NMDA receptors. We found that glycine treatment of wild-type NMDA receptors led to recruitment of the adaptor protein 2 (AP-2), and subsequent internalization after activating the receptors by NMDA plus glycine. However, with a glycine-binding mutant of GluN1 - N710R/Y711R/E712A/A714L - we found that treating with glycine did not promote recruitment of AP-2 nor were glycine-treated receptors internalized when subsequently activated with NMDA plus glycine. Likewise, GluN1 carrying a single point mutation - A714L - did not prime upon glycine treatment. Importantly, both of the mutant receptors were functional, as stimulating with NMDA plus glycine evoked inward currents.
Conclusions: Thus, we have identified a single amino acid in GluN1 that is critical for priming of NMDA receptors by glycine. Moreover, we have demonstrated the principle that while NMDA receptor gating and priming share a common requirement for glycine binding, the molecular constraints in GluN1 for gating are distinct from those for priming.
Glycine Transporter 1 Inhibitors Minimize the Analgesic Tolerance to Morphine.
Galambos A, Essmat N, Lakatos P, Szucs E, Boldizsar Jr I, Abbood S Int J Mol Sci. 2024; 25(20).
PMID: 39456918 PMC: 11508341. DOI: 10.3390/ijms252011136.
Brunetti V, Soda T, Berra-Romani R, De Sarro G, Guerra G, Scarpellino G Biomedicines. 2024; 12(4).
PMID: 38672234 PMC: 11048239. DOI: 10.3390/biomedicines12040880.
Epping L, Schroeter C, Nelke C, Bock S, Gola L, Ritter N Cell Mol Life Sci. 2022; 79(9):479.
PMID: 35951110 PMC: 9372018. DOI: 10.1007/s00018-022-04502-z.
Ion flux-independent NMDA receptor signaling.
Park D, Stein I, Zito K Neuropharmacology. 2022; 210:109019.
PMID: 35278420 PMC: 9365119. DOI: 10.1016/j.neuropharm.2022.109019.
Cappelli J, Khacho P, Wang B, Sokolovski A, Bakkar W, Raymond S iScience. 2022; 25(1):103539.
PMID: 34977503 PMC: 8689229. DOI: 10.1016/j.isci.2021.103539.